Trials / Conditions / Mesothelioma Peritoneum
Mesothelioma Peritoneum
7 registered clinical trials studyying Mesothelioma Peritoneum — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Oral AMXT 1501 Dicaprate in Combination With IV DFMO NCT05500508 | Aminex Therapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer NCT05451849 | TCR2 Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis NCT04024917 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma NCT04214015 | ProgenaBiome | — |
| Active Not Recruiting | Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer NCT03907852 | TCR2 Therapeutics | Phase 1 / Phase 2 |
| Completed | CAR T Cells in Mesothelin Expressing Cancers NCT03054298 | University of Pennsylvania | Phase 1 |
| Completed | Thrombin Generation and Platelet Activation in CRS/HIPEC NCT03034850 | Ziekenhuis Oost-Limburg | — |